DAVEVSMRNA• 3 Months (Normalized)
DAVE vs MRNA (Dave Inc. vs Moderna Inc.)
Showing Closing Date Range from Jun, 25 to Sep, 23, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DAVE Performance $328.43
+1.76%
Dave Inc.
Normalized Baseline0.00%
MRNA Performance $185.05
+209.71%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-207.95%
MRNA outperforming by 207.95%
DAVEMRNA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DAVE MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | DAVE Price | DAVE Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $328.43 | +1.76% | $185.05 | +209.71% | -207.95% |
| Sep 22, 2026 | $347.77 | +7.75% | $182.56 | +205.54% | -197.79% |
| Sep 21, 2026 | $350.65 | +8.64% | $172.94 | +189.44% | -180.80% |
| Sep 18, 2026 | $337.82 | +4.67% | $154.04 | +157.81% | -153.14% |
| Sep 17, 2026 | $356.49 | +10.45% | $158.07 | +164.55% | -154.10% |
| Sep 16, 2026 | $365.83 | +13.35% | $145.62 | +143.72% | -130.37% |
| Sep 15, 2026 | $374.67 | +16.09% | $143.77 | +140.62% | -124.53% |
| Sep 14, 2026 | $365.78 | +13.33% | $146.69 | +145.51% | -132.18% |
| Sep 11, 2026 | $350.71 | +8.66% | $143.97 | +140.95% | -132.29% |
| Sep 10, 2026 | $358.36 | +11.03% | $136.62 | +128.65% | -117.62% |
| Sep 09, 2026 | $361.88 | +12.12% | $135.61 | +126.96% | -114.84% |
| Sep 08, 2026 | $376.38 | +16.62% | $140.33 | +134.86% | -118.24% |
| Sep 04, 2026 | $380.69 | +17.95% | $145.55 | +143.60% | -125.65% |
| Sep 03, 2026 | $390.86 | +21.10% | $148.87 | +149.15% | -128.05% |
| Sep 02, 2026 | $372.85 | +15.52% | $150.81 | +152.40% | -136.88% |
Page 1 of 5